Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 523 entries
View as:

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT04642430 Org: User:
Start: 07/06/21 End: 12/31/27 Due: 12/31/28

The Effectiveness of Online Treatment for Insomnia in Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02272712 Org: User:
Start: 05/31/14 End: 01/31/22 Due: 01/31/23

Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00350688 Org: User:
Start: 11/30/05 End: 04/30/10 Due: 04/30/11

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00966472 Org: User:
Start: 03/31/09 End: 09/30/14 Due: 09/30/15

Breaststroke Swimming After Breast Cancer Treatment/Surgery as a Means of Treatment for Seroma, Lymphedema, and Chronic Arm and Chest Pain

Phase: N/A Priority: Normal
NCT ID: NCT04080934 Org: User:
Start: 01/01/23 End: 12/31/25 Due: 12/31/26

PECI/SPB vs Intercostal Nerve Block for the Management of Postoperative Pain in Latissimus Dorsi Flap Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT02821676 Org: User:
Start: 06/30/16 End: 06/30/17 Due: 06/30/18

Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT01461733 Org: User:
Start: 07/31/07 End: 12/31/09 Due: 12/31/10

REaCT-vascular Access Her2 Negative Vascular Access Strategies for (Neo) Adjuvant Breast Cancer Treatment Without Trastuzumab

Phase: N/A Priority: Normal
NCT ID: NCT02688998 Org: User:
Start: 04/30/16 End: 02/28/19 Due: 02/28/20

Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia

Phase: N/A Priority: Normal
NCT ID: NCT04255147 Org: User:
Start: 10/17/22 End: 11/06/33 Due: 11/06/34

Blood Pressure Measurement: Should Technique Define Targets?

Phase: N/A Priority: Normal
NCT ID: NCT03267420 Org: User:
Start: 10/12/17 End: 08/31/19 Due: 08/31/20

Remote Electrocardiographic (ECG) ST-Monitoring (PROSE 3)in Post-op Patients

Phase: N/A Priority: Normal
NCT ID: NCT01423136 Org: User:
Start: 10/31/10 End: 10/31/12 Due: 10/31/13

Resurfacing Hemiarthoplasty Versus Conventional Stemmed Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT00664989 Org: User:
Start: 08/31/07 End: 04/30/09 Due: 04/30/10

Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study

Phase: N/A Priority: Normal
NCT ID: NCT02034838 Org: User:
Start: 01/31/14 End: 09/30/15 Due: 09/30/16

Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection

Phase: N/A Priority: Normal
NCT ID: NCT06827041 Org: User:
Start: 02/22/24 End: 02/28/25 Due: 02/28/26

Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT00440206 Org: User:
Start: 09/30/01 End: 12/31/01 Due: 12/31/02

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00967148 Org: User:
Start: 06/30/09 End: 09/30/10 Due: 09/30/11

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Phase: N/A Priority: Normal
NCT ID: NCT00967304 Org: User:
Start: 11/30/08 End: 07/31/16 Due: 07/31/17

Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT03147859 Org: User:
Start: 11/01/17 End: 12/31/23 Due: 12/31/24

Comparative Effectiveness of Peripheral Nerve Blocks for Outpatient Shoulder Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03309644 Org: User:
Start: 04/30/11 End: 12/31/16 Due: 12/31/17

The VICTORY Trial: Virtual, Innovative, Postsurgical Care To Optimize Return Home for Older People With frailtY

Phase: N/A Priority: Normal
NCT ID: NCT06503198 Org: User:
Start: 01/29/25 End: 01/31/30 Due: 01/31/31

Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic

Phase: N/A Priority: Normal
NCT ID: NCT04588415 Org: User:
Start: 01/03/21 End: 02/17/22 Due: 02/17/23

The Influence of Concurrent Oral Calcium Carbonate Supplementation on Steady State Pharmacokinetics of Oral Raltegravir.

Phase: N/A Priority: Normal
NCT ID: NCT04258475 Org: User:
Start: 12/09/20 End: 01/01/25 Due: 01/01/26

Integrating ChatGPT in Anesthesia

Phase: N/A Priority: Normal
NCT ID: NCT06652854 Org: User:
Start: 12/09/24 End: 06/30/25 Due: 06/30/26

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04549207 Org: User:
Start: 10/09/20 End: 06/30/26 Due: 06/30/27

Dislocation Precautions

Phase: N/A Priority: Normal
NCT ID: NCT03806114 Org: User:
Start: 06/21/19 End: 12/21/23 Due: 12/21/24